April 6, 2026

Quadrise moves to make marine fuel switching easier to assess

Quadrise has launched a vessel-based comparison tool to help shipowners judge whether its marine fuels offer a practical commercial advantage...

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Uncovering a Potential 86% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector as an emergent player in RNA-based therapies. With a focus on cardiomyopathies, the company is strategically positioned to..

Bausch + Lomb (BLCO) Stock Analysis: Eyeing an 11.96% Upside with Strategic Growth in Global Eye Health

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector under the Medical Instruments & Supplies industry, has been crafting a significant presence in the global eye health..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 20% Upside Potential Beckons Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, continues to capture investor interest with its impressive market capitalization of $7.63 billion. As a commercial-stage biotechnology company,..

BridgeBio Pharma, Inc. (BBIO): Analyst Consensus Sees 37.58% Upside Potential in Biotech Innovator

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has emerged as a focal point for investors keen on the biotechnology sector, thanks to its dynamic approach to addressing genetic diseases. Headquartered in Palo..

Prestige Consumer Healthcare (PBH) Stock Analysis: A 49.58% Upside Potential with Strong Buy Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out in the healthcare sector as a key player in the over-the-counter (OTC) health and personal care market. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 20% Potential Upside for Investors

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Based in Bedford, Massachusetts, the company has..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 25% Potential Upside Amidst Market Challenges

Alkermes plc (NASDAQ: ALKS), the Dublin-based biopharmaceutical company, presents an intriguing investment opportunity within the healthcare sector, specifically in the specialty and generic drug manufacturing industry. With a market capitalization..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 32.5% Upside Potential in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, stands out as a compelling investment opportunity, particularly for those interested in healthcare innovations. With a market capitalization..

Legend Biotech Corporation (LEGN) Stock Analysis: Potential 198.94% Upside in the Booming Cell Therapy Market

Legend Biotech Corporation (NASDAQ: LEGN) presents a compelling opportunity for investors seeking exposure to the innovative field of biotechnology, particularly in the burgeoning cell therapy sector. With a market capitalization..

Halozyme Therapeutics, Inc. (HALO): Investor Outlook Reveals 31.63% Upside Potential in Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology industry, is drawing attention from investors with its impressive valuation metrics and strategic partnerships. With a market capitalization of..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring an 81% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a key player in the healthcare sector, is capturing investor attention with a compelling upside potential of 81.02%. Specializing in medical devices, this San Francisco-based..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 7.37% Upside Potential Amidst Strong Buy Ratings

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling case for investors seeking growth opportunities. With a current..

Repligen Corporation (RGEN) Investor Outlook: Potential 58.62% Upside Sparks Interest

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector, specializes in developing and commercializing bioprocessing technologies that are indispensable for the life sciences industry. Headquartered in Waltham, Massachusetts,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 50.66% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors eyeing significant growth potential. With..

Oscar Health, Inc. (OSCR) Stock Analysis: Unpacking the 29% Potential Upside

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, has been making waves in the healthcare plans industry with its innovative approach to health insurance. With a market capitalization of..

BrightSpring Health Services, Inc. (BTSG) Investor Outlook: A 22% Upside Potential Amid Robust Revenue Growth

For investors seeking opportunities in the healthcare sector, BrightSpring Health Services, Inc. (BTSG) presents a compelling case. As a leading provider of home and community-based healthcare services in the United..

Sarepta Therapeutics, Inc. (SRPT): Stock Analysis Reveals Challenges Amidst Biotech Innovations

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a prominent player within the biotechnology sector, focusing on the development of genetic therapeutic modalities targeting rare diseases. The company’s current market capitalization..

West Pharmaceutical Services (WST) Stock Analysis: A Steady Healthcare Innovator with 24% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector, specializing in medical instruments and supplies, presents an intriguing opportunity for investors seeking a blend of stability..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with a 19.55% Potential Upside

Investors eyeing the biotechnology sector may find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) a compelling opportunity, given its promising pipeline and a notable 19.55% potential upside. This Dublin, Ireland-based company is..

Search

Funds

April 6, 2026

Quadrise moves to make marine fuel switching easier to assess

Quadrise has launched a vessel-based comparison tool to help shipowners judge whether its marine fuels offer a practical commercial advantage...
Search

Funds

April 6, 2026

FTSE 100

Funds